Kemnay Advisory Services’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.9K Buy
+1,662
New +$14K ﹤0.01% 620
2026
Q2
– Sell
-18,359
Closed -$106K – 1371
2026
Q1
$106K Buy
18,359
+9,879
+116% +$65.5K 0.02% 102
2025
Q4
$66.6K Buy
+8,480
New +$66.7K 0.01% 244

Other funds holding XERS

Kemnay Advisory Services's XERS Position: Q3 2026 in Review

Kemnay Advisory Services opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 1,662 shares worth $15.9K. The stake represents ﹤0.01% of the portfolio and ranks #620 among its holdings. This is a return to the name: Kemnay Advisory Services previously reported a position in XERS as recently as Q1 2026.

Kemnay Advisory Services first reported a position in XERS in Q4 2025 and has held it in 3 quarters since. The position peaked at $106K in Q1 2026. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Kemnay Advisory Services held 1,662 shares of Xeris Biopharma Holdings worth $15.9K as of Q3 2026.
  • Xeris Biopharma Holdings was a new Kemnay Advisory Services position in Q3 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #620 holding.
  • Kemnay Advisory Services first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • Kemnay Advisory Services's Xeris Biopharma Holdings position peaked at $106K in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.